Home › NCT06344143
Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Patients ages 18 years and older. 2. Presence of adrenal incidentaloma by cat scan (CT) or magnetic resonance imaging (MRI) examination. 3. 1-mg Dexamethasone suppression test cortisol ≤ 5 μg/dL with adequate dexamethasone level. Exclusion Criteria: 1. 1-mg Dexamethasone suppression test cortisol \> 5 μg/dL with adequate dexamethasone level. Patients who fail to suppress below this level will be considered to have Cushing's syndrome and will be referred for appropriate treatment. 2. Current or recent (3 months) history of use of glucocorticoid medication (including joint injections of steroids). 3. History of uncontrolled hypertension or history of hypertension with more than 2 medications. 4. History of uncontrolled type 2 Diabetes Mellitus or history of diabetes mellitus with A1c\>7.5. 5. Known History of osteoporosis 6. Documented Clinical Cushing's disease. 7. Clinical suspicion of adrenal carcinoma. 8. History of alcohol abuse/dependence. 9. History of cirrhosis of liver. 10. History of hepatitis B or C infection regardless of treatment. 11. History of type 1 diabetes. 12. History of hemochromatosis. 13. History of autoimmune hepatitis. 14. History of Wilson's disease.
About the study
The aim of the proposed study is to estimate the incidence of Mild Autonomous Cortisol Secretion (MACS) in patients with Adrenal Incidentaloma (AI) and evaluate the available diagnostic tests to determine the most sensitive and specific combination of tests for assessing MACS from adrenal adenoma for prediction of the phenotype associated with cortisol excess. As well as following the patients for 4 years and see if anything changes.
What is being tested
- Various labs and imaging tests (diagnostic test)
Sponsor: The Cleveland Clinic · Participants: 20 · Started: Nov 20, 2024
Contact the study team
- Kimberly Jenkins · Phone: 216-445-4791
- Andrea Parianos · Phone: 216 210-7832
Official record on ClinicalTrials.gov — NCT06344143
Locations in the U.S.
| Ohio | The Cleveland Clinic Foundation, Cleveland |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.